Clinical Trial Update: The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in Smokers [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating inhaled aclidinium bromide/formoterol fumarate on inspiratory pleural pressures in smokers; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Drugs mentioned

• Aclidinium bromide/formoterol fumarate (Aclidinium bromide/formoterol fumarate)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Smoking | Phase 3 | Status: COMPLETED